org placeholder image

John Yeoman

Principal Scientist, Medicinal Chemistry at Recludix Pharma

  • LinkedIn

Email Email: j****@recludix.com

phone noPhone Number: (***)-***-****

• Accomplished medicinal chemistry researcher with impactful contributions in neuroscience and cardiovascular/metabolic therapeutic areas and experience with kinase, GPCR, protein-protein...

Read More

map
RECLUDIX PHARMA

RECLUDIX PHARMA

  • Employees count Employees 1-10
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Recludix Pharma Org Chart and Mapping

Employees

Thomas Davis

Vice President of Biology

Megan Soto

Discovery Technology Intern

John Yeoman

Principal Scientist, Medicinal Chemistry

Kaylin Holdeman

Senior Research Associate - Immunobiology

Ksenya Katsenelson

Senior Scientist, Discovery Technology

Frequently Asked Questions Regarding John Yeoman

Answer: John Yeoman works for Recludix Pharma as Principal Scientist, Medicinal Chemistry

Answer: John Yeoman’s role in Recludix Pharma is Principal Scientist, Medicinal Chemistry

Answer: John Yeoman's email address is j***@gmail.com

Answer: John Yeoman's business email address is j****@recludix.com

Answer: John Yeoman’s direct phone number is (***)-***-****

Answer: John Yeoman works in the industry of: Biotechnology

Answer: John Yeoman is the current Principal Scientist, Medicinal Chemistry at Recludix Pharma.... Read More

Answer: John Yeoman works Recludix Pharma located at Roselle St, San Diego, , 2142, California, 11040, United States

Answer: Recludix Pharma's Principal Scientist, Medicinal Chemistry is John Yeoman

Answer: John Yeoman contact details:

  • Phone number  :  (***)-***-****
  • Email  :  j****@recludix.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access